
    
      PRIMARY OBJECTIVE:

      I. To use a Mendelian randomization study design to determine whether genetically predicted
      decreased testosterone levels are associated with an increased risk of dementia.

      SECONDARY OBJECTIVE:

      I. To examine whether genetically predicted decreased testosterone levels are associated with
      worse cognitive function and adverse mental health outcomes.

      OUTLINE:

      Patients' records from institutional or national biobanks are reviewed.
    
  